Top compounds associated with response to RP11-812E19.9


Feature Type Standardized
Nominal ANOVA
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA SB-525334 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA canertinib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.027 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC 0.019 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA narciclasine CTRPv2 pan-cancer AAC -0.012 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.012 0.7
Download CSV